Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.25 USD
Change Today -0.25 / -3.85%
Volume 377.0
VSUL On Other Exchanges
As of 8:10 PM 11/25/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

500 Union Street

Suite 420

Seattle, WA 98101

United States

Phone: 206-903-1351

Fax: 206-826-0451

Visualant, Inc. focuses on the development of a proprietary technology, which is capable of identifying and authenticating almost any substance using light to create, record and detect the digital ‘signature’ of the substance. The company calls this its ‘ChromaID’ technology. Products The company’s first delivered product, the ChromaID Lab Kit, scans and identifies solid surfaces. The company is marketing this product to customers who are considering licensing the technology. Target markets include, but are not limited to, commercial paint manufacturers, pharmaceutical equipment manufacturers, process control companies, currency paper and ink manufacturers, security card manufacturers, cosmetic companies, scanner manufactures, water purification and quality companies, and food processing companies. The company’s second product, the ChromaID Liquid Lab Kit, scans and identifies liquids. This product is in prototype form. Similar to the company’s first product, it would be marketed to customers who are considering licensing the technology. Rather than use an LED (light-emitting diode) emitter to reflect light off of a surface that is captured by a photodiode to generate a ChromaID signature the liquid analysis product shines light through the liquid (transmissive) with the LEDs positioned on one side of the liquid sample and the photo detectors on the opposite side. This device is in a functional state in the company’s laboratory and it anticipates having a Liquid ChromaID Lab Kit available for customers by the company during the fall of 2015. Target markets include, but are not limited to, water companies, petrochemical companies, pharmaceutical companies, and various consumer applications. The ChromaID Lab Kits allows potential licensors of the company’s technology to work with its technology and develop solutions for their particular application. The company owns TransTech Systems, Inc. (TransTech) as an adjunct to its business. TransTech is a distributor of products, including systems solutions, components and consumables, for employee and personnel identification in government and the private sector, document authentication, access control, and radio frequency identification. TransTech provides these products and services, along with marketing and business development assistance to value-added resellers and system integrators throughout North America. The company intends, however, to further develop and market its ChromaID technology. Invention Development Management Company (IDMC) Relationship The company has a strategic relationship with IDMC, a subsidiary of Intellectual Ventures. Intellectual Ventures owns approximately 40,000 IP assets and has global relationships for the invention of technology, the filing of patents and the licensing of intellectual property. IDMC has worked to expand the reach and the potential application of the ChromaID technology and has filed 10 patents base on the ChromaID technology, which it has licensed to the company. In connection with IDMC’s work to expand the company’s intellectual property portfolio, it agreed to curtail outbound marketing activities of the company’s technology through the fourth calendar quarter of 2014. Suppliers Evolis, Fargo, Ultra Electronics - Magicard Division and NiSCA are major vendors of TransTech. Strategy Key aspects of the company’s strategy are to customize and refine its solutions to meet potential customers’ needs; continue to expand applications for ChromaID technology; target potential high-volume markets; pursue strategic acquisitions and alliances; and target additional markets. Research and Development The company spent $362,661 on development activities for the year ended September 30, 2015. Patents The company’s 9 patents, 21 patent applications, and 2 registered trademarks, as well as its trade secrets, copyrights and other intellectual property rights are important assets for the company. The company’s patents would expire at various times between 2027 and 2033. The patents that have been granted to the company comprise: In August 2011, the company was issued US Patent No. 7,996,173 B2 entitled ‘

Page 12Next Page

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSUL:US $6.25 USD -0.25

VSUL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Thermo Fisher Scientific Inc $138.66 USD +0.70
View Industry Companies

Industry Analysis


Industry Average

Valuation VSUL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.9x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact VISUALANT INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at